Thursday, July 19, 2018
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSX: $TGOD.TO, TSXV: $EMH.V, TSXV: $N.V, CSE: $IAN.C, CSE: $BE.C
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: TSX: $TGOD.TO,
TSXV: $EMH.V, TSXV: $N.V, CSE: $IAN.C, CSE: $BE.C
July 19th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) and its drug
delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –June 21, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07194Potcasts-TSXV-TGOD-EMH-N-CSE-IAN-BE.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast; looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today we will be looking at announcements from The Green Organic Dutchman Holdings Ltd. trading
on the TSX as TGOD, Emerald
Health Therapeutics, Inc. trading on the TSX-Venture as EMH, Namaste
Technologies Inc. trading on the TSX-Venture as N, iAnthus Capital Holdings,
Inc. trading on the CSE as IAN and the OTCQB as ITHUF and Beleave Inc. trading
on the CSE as BE.
The Green
Organic Dutchman Holdings Ltd. announced its intention to complete a spinoff
transaction by way of plan of arrangement, pursuant to which the Company will
distribute a dividend consisting of a warrant in a new corporation (“TGOD Acquisitions”) to shareholders.
The new corporation will be engaged in the acquisition and development of worldwide
opportunities.
TGOD has met
with emerging cannabis companies from around the globe
and acquired a deep understanding,
including proprietary knowledge, of all facets of the
cannabis industry. These companies are not considered core assets in
TGOD’s business plan, and accordingly, they have not been
pursued to date. However, the Company now wishes to monetize this
unique situation for the benefit of TGOD shareholders. After
consultation with multiple financial institutions, TGOD Acquisitions plans
to execute a series of staged financings and acquisitions
leading to a late 2018 target IPO date.7
Emerald
Health Therapeutics, Inc. have signed a definitive agreement to acquire
the remaining shares of Northern Vine Canada Inc. (Northern Vine), owned by
Abattis Bioceuticals Corp. (CSE:ATT) (OTC:ATTBF), for $2 million in cash and $4
million in shares of Emerald stock. This transaction increases Emerald’s
ownership of Northern Vine from 65% to 100%. Northern Vine is a Licensed Dealer
(LD) under the provisions of the Canadian Controlled Drugs and Substances Act.
“Product
innovation is a primary pillar of Emerald’s global business strategy. The
acquisition of Northern Vine allows us to leverage its dealer license and
research and development facility to advance our research plans to develop
cannabis formulations supporting new products for both recreational purposes
and to treat a broad spectrum of human conditions and diseases,” said Chris
Wagner, CEO of Emerald. “The dealer license would also enable Emerald to cost
effectively source non-dried-flower cannabis products from suppliers in other
countries.”
Namaste
Technologies Inc. announced that the company has submitted applications to the
Apple and Google Play stores in order to launch its latest mobile application,
Uppy Cannabis Journal. Uppy Cannabis Journal is the first artificial
intelligence ("AI") driven medical cannabis app, which is designed to
collect direct feedback on cannabis strains and over time provide strain and
cannabis hardware recommendations. Namaste has implemented its AI technology through
the Company's wholly owned subsidiary Findify AB ("Findify" or
"Findify.io") and has fed over 2 million pieces of unique data to the
platform which forms the base on which the algorithm will evolve and adapt
itself to better understand the effects of cannabis strains in relation to
treatment of many symptoms.
Through Uppy
Cannabis Journal, Namaste's customers and medical cannabis patients will have
the access to journal their experiences using various strains of cannabis to
treat their symptoms. The data collected over time will allow the algorithm to
characterize the way different strains of cannabis benefit different people
suffering from different symptoms. The goal of the Uppy Cannabis Journal is to
develop a shopping experience whereby patients are provided with the best
possible strain recommendations personalized for their needs, based on factual
data collected through Namaste's network of e-commerce sites, combined with
user-feedback and AI technology.
iAnthus
Capital Holdings, Inc., which owns, operates and partners with licensed
cannabis operations throughout the United States, announced that Mayflower
Medicinals, Inc. ("Mayflower"), a Massachusetts non-profit Registered
Marijuana Dispensary ("RMD") license holder affiliated with the
Company, is opening its flagship medical cannabis dispensary in Boston.
Located in
the neighborhood of Allston, the dispensary will offer patients a full spectrum
of medical cannabis products in the form of flower, tinctures, concentrates,
oils and vaporizers. Mayflower is the second license holder to open a
dispensary within the city of Boston. This inaugural Mayflower
location is the 34th dispensary to open within the commonwealth of
Massachusetts, which has a population of approximately 6.7 million people.
Beleave Inc.
announced the acquisition of 100% of the outstanding shares of Seven Oaks Inc.
in an all share deal valued at $3,000,000.
"Seven
Oaks has a proven track record of working collaboratively to secure wholesale
and distribution agreements with retailers across Canada," said Beleave
CEO, Andrew Wnek. "Beleave breaking into the recreational market with
solid agreements and impactful branding will be a monumental development for
us. Seven Oaks' upcoming distribution will not only improve access to our
products for many Canadians, it is also continuing our commitment to driving
profitability and value for our shareholders."
Seven Oaks'
branding appeals to consumers, both conceptually and in the quality it invokes,
attracting them to become repeat customers. This acquisition bridges the gap
between sourcing cannabis products from an established producer and retailing
by leveraging Seven Oak's marketing platform to provide consistent,
recognizable quality across Canada.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp Stocks? Check out our stock directory of publicly
traded CSE, TSX, TSXV, OTC, NASDAQ,
NYSE, ASX Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Wednesday, July 18, 2018
Investorideas.com - CSE New #Cannabis Stock Listing: Chemesis International Inc. (CSI)
Investorideas.com - CSE New #Cannabis Stock Listing: Chemesis International Inc. (CSI)
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: FluroTech Ltd. (TSXV: TEST) Announces the Ability to Biomark Cannabis Oil
Investorideas.com - #Cannabisstocks: FluroTech Ltd. (TSXV: TEST) Announces the Ability to Biomark Cannabis Oil
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: True Leaf (CSE: MJ) (OTCQB: TRLFF) Campus Project Remains on Schedule for Fall 2018 Completion
Investorideas.com - #Cannabisstocks: True Leaf (CSE: MJ) (OTCQB: TRLFF) Campus Project Remains on Schedule for Fall 2018 Completion
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: NASDAQ: $CRON, TSX: $EMC.TO, TSXV: $GENE.V, TSXV: $N.V, CSE: $MJ.C
Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move: NASDAQ: $CRON,
TSX: $EMC.TO, TSXV: $GENE.V, TSXV: $N.V, CSE: $MJ.C
July 18th Potcast
sponsored by Lexaria Bioscience Corp. ( CSE: $LXX.C ) (OTC: $LXRP) a #Cannabis
company with a new disruptive drug delivery platform: DehydraTECH
Pt. Roberts, WA; Delta, BC –July 18, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/07185Potcasts-NASDAQ-CRON-TSXV-EMC-GENE-N-CSE-MJ.asp
Today’s podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast – looking
at cannabis news, stocks to watch as well as insights from thought leaders and
experts.
Today’s potcast was sponsored by Kelowna based Lexaria Bioscience Corp trading on the CSE under symbol LXX and on
the OTC as LXRP. Lexaria has developed a new disruptive
drug delivery platform: DehydraTECH The Company’s patented technology changes
the way Active Pharmaceutical Ingredients (“APIs”) enter the body orally:
1) Masks unwanted tastes – eliminates the need for sugar-filled edibles.
2) Reduces time of onset – effects are felt within 15-20 min vs. 60-120
min.
3) Avoids first-pass liver metabolism
4) Increases bio-absorption by 5-10X
The Company’s DehydraTECH™ technology is patent-protected for multiple
APIs: Cannabidiol (CBD), Tetrahydrocannabinol (THC), Non-steroidal
anti-inflammatory drugs (NSAIDs) such as ibuprofen, Nicotine and Fat soluble
vitamins.
Today we will be looking at announcements from Cronos Group Inc. trading on the NASDAQ and
TSX as CRON, Emblem Corp. trading on the TSX-Venture as EMC and the OTCBB as EMMBF, INVICTUS MD STRATEGIES CORP trading on
the TSX-Venture as GENE and the OTC as IVITF, Namaste Technologies Inc.
trading on the TSX-Venture as N and True Leaf Medicine International Ltd.
trading on the CSE as MJ and the OTCQB as TRLFF.
Cronos Group
Inc. announced that it has entered into a joint venture partnership with a
group of investors led by Bert Mucci, one of Canada's most sophisticated
greenhouse operators and builders. This partnership will function through a
newly formed entity, Cronos Growing Company Inc., which will develop, construct
and operate a state-of-the-art purpose-built greenhouse for cannabis production
in Kingsville, Ontario.
Cronos
GrowCo is a 50/50 partnership between the Company and the Greenhouse Partners.
It will leverage over three decades of Bert Mucci's experience in designing,
building and operating sophisticated large-scale greenhouses. Bert Mucci, has a
long history of greenhouse growing experience and will bring a wealth of
knowledge and expertise to this collaboration. He has made significant contributions
to the horticultural industry in Canada, including investments in innovative
technologies and environmental stewardship. With a proven track record of
growth and expansions in vertically integrated operations - from seed to
package. Bert Mucci has overseen thousands of employees and over 200 acres of
fruit and vegetable greenhouses in southwestern Ontario.
Emblem Corp.
announced today that it is making a strategic equity investment into Natura
Naturals Inc., a 662,000 square foot licensed greenhouse cultivator of medical
cannabis pursuant to Health Canada's Access to Cannabis for Medical Purposes
Regulations ("ACMPR"). The companies have also signed a three-year
cannabis supply agreement to provide Emblem up to 3,000kg of high-quality cannabis
flower per year from Natura’s Phase 1 cultivation facility.
Based in
Leamington, Ontario, Natura employs proprietary processes to produce
high-quality cannabis in its state-of-the-art greenhouse facility. The first
155,000 square feet of the facility is currently being converted as part of its
Phase 1 retrofit and is expected to be complete in August 2018 and capable of
producing 15,000kg of cannabis per year. The Phase 2 conversion will retrofit
the remaining 507,000 square feet for cannabis cultivation and is expected to
bring total production capacity to approximately 70,000kg per year by mid-2019.
Natura holds a genetic library of 32 cannabis strains, which will be made
available to Emblem.
Post-closing,
Emblem will own approximately 5% of Natura’s outstanding shares on a
non-diluted basis, and 7% on a fully diluted basis. Closing of the Equity
Investment is subject to customary conditions and is expected to close later
this week.
INVICTUS MD STRATEGIES CORP. announced that further to its news release dated May 16, 2018, it has
successfully entered into a definitive option agreement with a Late-Stage
Applicant under the Access to Cannabis for Medical Purposes Regulations ("ACMPR") to acquire 100% of the
outstanding shares of OptionCo from its current shareholders.
OptionCo has
a cannabis production and research facility located in Delta, British Columbia,
and an additional property located in Mission, British Columbia that is
currently awaiting construction of a 350,000 square foot purpose-built indoor
facility, which will be built in multiple phases with completion set for the
fourth quarter of 2019. The Mission Location is located on 32-acres of
buildable land. The property is eligible for wholesale energy costs with 38 MG
Watt service at the property line, and access to an ample water supply from
underground aquifers.
The Delta
Facility has completed its pre-license inspection from Health Canada and
expects to receive its license to cultivate medical cannabis under the ACMPR in
short order.
Namaste Technologies
Inc. announced that the Company has signed an e-commerce and technology
services agreement with BlissCo Cannabis Corp Inc. (CNSX: BLIS), whereby
Namaste will provide services including access to Namaste's technology
platforms, software integrations and e-commerce services including those
powered by Namaste's e-commerce artificial intelligence (AI) platform,
Findify.io.
Under the
terms of this Agreement, Namaste will leverage its proprietary technology
platforms to develop an innovative online marketplace in partnership with
BlissCo to enhance BlissCo's patient experience. BlissCo is a Canadian licensed
producer and distributor of high-quality medical cannabis that operates an
Access to Cannabis for Medical Purposes Regulations ("ACMPR")
cultivation facility based in Langley, BC.
True Leaf
Medicine International Ltd., a plant-forward wellness brand for people and
their pets, announced today that construction of its cannabis cultivation and
production facility, True Leaf Campus, remains on schedule for fall 2018
completion.
The first
phase of the project includes a two-storey 9,000 square foot central hub for
the initial grow area, laboratory services, whole-plant extraction, and the
production of therapeutic cannabis products, followed by a 16,000 square foot
wing for cannabis cultivation. The facilities, being built in Lumby, British
Columbia, will be a hub for the development of the company’s medicinal cannabis
products.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Lexaria Bioscience Corp. has developed and
out-licenses its disruptive delivery technology that promotes healthier
ingestion methods, lower overall dosing and higher effectiveness of lipophilic
active molecules. Lexaria has multiple patents pending in over 40 countries
around the world and has patents granted in the USA and in Australia for
utilization of its DehydraTECHTM delivery technology. Lexaria's technology
provides increases in intestinal absorption rates; more rapid delivery to the
bloodstream; and important taste-masking benefits, for orally administered
bioactive molecules including cannabinoids, vitamins, non-steroidal
anti-inflammatory drugs (NSAIDs), nicotine and other molecules. www.lexariabioscience.com
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on Linkedin.com
, the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp. Disclosure Lexaria
Bioscience Corp. ( CSE: LXX) (OTC: LXRP) is a media sponsor of the podcast
starting July 5 2018 more info http://www.investorideas.com/About/News/Clientspecifics.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Do you trade or invest in Marijuana / Hemp
Stocks? Check out our stock directory of
publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX
Marijuana / Hemp Stocks
Join our Group on Linkedin and talk about - Marijuana / Hemp Stocks - News and Trends in Green Investing
Subscribe to:
Posts (Atom)